Compositions and methods for reactivating latent immunodeficiency virus
US11807852B2 · kind B2 · utility
0Cited by
24References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 20, 2021 |
| Grant date | Nov 7, 2023 |
| Priority date | — |
| Expiry date | Aug 19, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/531
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides compositions and methods for reactivating latent immunodeficiency virus and/or reducing transcription of HIV integrated into the genome of an HIV-infected cell. The present disclosure provides compositions and methods for treating an immunodeficiency virus infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.